MAINZ and TÜBINGEN, Germany, June 12, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ribonucleic acid (“mRNA”). The all-stock transaction will bring together two highly complementary companies based in Germany and will build on BioNTech's proven track record and established position in the global mRNA industry.
Chime's decision to go public comes after a steep valuation cut and years of private market delays across the fintech sector. The company provides online banking services.
COOTAMUNDRA, Australia, June 10, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited (the “Company”) (NASDAQ: COOT), a manufacturer and seller of sustainable edible oils to customers globally, announced that it has received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it has not regained compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450(b)(1) requires listed companies to maintain stockholders' equity of at least $10,000,000 (the “Stockholders' Equity Requirement”).
![]() NAQ 2 months ago | Other | €0.21 Per Share |
![]() NAQ 6 months ago | Other | €0.21 Per Share |
![]() NAQ 8 months ago | Other | €0.21 Per Share |
![]() NAQ 11 months ago | Other | €0.21 Per Share |
![]() NAQ 13 Mar 2024 | Other | €0.19 Per Share |
23 Jul 2025 (41 Days) Date | | - Cons. EPS | - EPS |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
29 Jan 2025 Date | | - Cons. EPS | - EPS |
24 Oct 2024 Date | | - Cons. EPS | - EPS |
16 Oct 2024 Date | | - Cons. EPS | - EPS |
![]() NAQ 2 months ago | Other | €0.21 Per Share |
![]() NAQ 6 months ago | Other | €0.21 Per Share |
![]() NAQ 8 months ago | Other | €0.21 Per Share |
![]() NAQ 11 months ago | Other | €0.21 Per Share |
![]() NAQ 13 Mar 2024 | Other | €0.19 Per Share |
23 Jul 2025 (41 Days) Date | | - Cons. EPS | - EPS |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
29 Jan 2025 Date | | - Cons. EPS | - EPS |
24 Oct 2024 Date | | - Cons. EPS | - EPS |
16 Oct 2024 Date | | - Cons. EPS | - EPS |
Financial - Data & Stock Exchanges Industry | Financial Services Sector | Ms. Adena T. Friedman CEO | XBER Exchange | US6311031081 ISIN |
US Country | 9,377 Employees | 14 Mar 2025 Last Dividend | 29 Aug 2022 Last Split | 1 Jul 2002 IPO Date |
Nasdaq, Inc. is a global technology company that serves capital markets and a variety of other industries, marking its presence worldwide. The company operates across three primary segments: Capital Access Platforms, Financial Technology, and Market Services. Initially known as The NASDAQ OMX Group, Inc., the company underwent a name change to Nasdaq, Inc. in September 2015, continuing its legacy since its inception in 1971. With its headquarters located in New York, New York, Nasdaq, Inc. has been at the forefront of providing innovative financial products, technology solutions, and market services designed to enhance the efficiency and transparency of the capital markets.
This segment is integral to Nasdaq's offerings, focusing on the distribution of historical and real-time market data. It encompasses developing and licensing Nasdaq-branded indices and financial products, providing investor relations intelligence, governance solutions, ESG solutions, insights, and workflow solutions. It also includes the operation of listing platforms, making it a crucial component for enterprises seeking capital market access and compliance.
Nasdaq's Financial Technology segment presents a range of solutions aimed at combating financial fraud and enhancing regulatory compliance, including:
The Market Platforms segment of Nasdaq, Inc. provides a variety of trading and clearing services across multiple asset classes. These include: